Heart FailureNEHFNCT02425488
Nursing Therapeutics Education and Heart Failure (HF): a Study Protocol
A study testing Nursing therapeutics education in people with Heart Failure and Arrhythmia, run by University of Turin, Italy at 2 sites in Italy.
Trial summary
Purpose: Heart Failure (HF) is a clinical multifactorial syndrome, it can cause arrhythmias for which international guidelines suggest the implantation of an implantable cardiac defibrillator (ICD). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Heart Failure, Arrhythmia
- What is being tested?
- Nursing therapeutics education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 2 sitesItaly
- Study dates
- Apr 2015to Apr 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients affected by heart failure following elective hospitalization during which an ICD was implanted on an arrhythmic and/or ischemic basis.
- Patients who have given written consent for the research.
Who cannot join
- Patients with syndromes and diseases that compromise their understanding of information, learning and all cognitive activities in general.
- Minors.
Trial locations and contacts
2 sites in 1 country.
Italy2 sites
Cardiovascular Department, Rivoli Hospital, ASL TO3
Rivoli, Turin, 10098
Cardiovascular Department, Città della Salute e della Scienza, University Hospital
Turin, 100126
About this study
Official title: Nursing Therapeutics Education and Heart Failure (HF): an Experimental Study
Purpose: Heart Failure (HF) is a clinical multifactorial syndrome, it can cause arrhythmias for which international guidelines suggest the implantation of an implantable cardiac defibrillator (ICD). The educational nursing program would improve clinical outcomes in patients with HF and ICD like control their sickness, known and acknowledge symptoms, improve their skills to self-care.
The main aim of this study is to assess how much the nursing-therapeutics skills and an educational intervention, in patients with HF during the follow-up period after the implantation of ICD reduces clinical costs, re-hospitalizations, and mortality at 180 days.
Read more
Methods: The investigators start a multicenter randomized clinical trial. The sample is made of 128 subjects (64 patients treatment group and 64 control group). The investigators measured the self-care level administering to HF patients the "Self-Care of Heart Failure Index (SCHFI) v. 6.2", and the self-perception of own life quality using a Numeric Rating Scale from 0 to 100. Secondary outcomes recorded are i) the numbers of accesses to the ED (Emergency Department) and/or hospitalizations during the follow-up period, ii) mortality rate due to HF, and iii) infection rate of the device pocket.
Data Analysis: Categorical variables will be presented in terms of frequencies and percentages. The statistical power was fixed at the 80%. Data will be considered significant for a p-value ≤ 0.05. The Cox proportional hazards model will be used to analyze mortality in subjects involved in the educational program.
Read the detailed description
Aims of the study The aim of this study is to examine the effects of a nursing intervention consisting of sanitary-therapeutic education during the follow-up period after the implantation of a defibrillator (ICD) in patients with congestive heart failure.
The effectiveness of the educational intervention will be assessed on the basis of the level of "self-care" in every individual and their lifestyle as well as on mortality rates, readmission to the hospital and ICD pocket infection.
Educational intervention will focus on
- Appropriate lifestyles
- Early recognition of signs/prodromal symptoms of HF
- Early recognition of signs of inflammation of the ICD-pocket
- Good management of the device
<!-- -->
- Therapy, body weight, diet, smoking, alcohol, rest, exercise, job, and sex
- Dyspnea, edema, and fovea, rapid weight gain, loss of appetite, fatigue, asthenia, insomnia, mental confusion
- Signs and symptoms of inflammation: hyperpyrexia, rubor, dolor, calor and tumor
- Identification tag, vibration, metal detectors, air travel, use of electronic devices, diagnostic PET and MRI Materials and methods A multicenter randomized controlled study will be performed. The research project will involve two clinical centers in northern Italy: the "Città della Salute e della Scienza" University Hospital of Turin, which includes the "Molinette" Hospital (coordinator center), and the TO3 ASL, which includes the "Associated Hospitals of Rivoli". Subject recruitment and data collection will take place until data saturation is achieved, with an estimated period of approximately 12 months from the beginning of the study. Participants Inclusion criteria:
- Patients affected by heart failure following elective hospitalization during which an ICD was implanted on an arrhythmic and/or ischemic basis.
- Patients who have given written consent for the research. Exclusion criteria:
- Patients with syndromes and diseases that compromise their understanding of information, learning and all cognitive activities in general.
- Minors. Primary outcome measures • Self-care levels (measured using the Self-Care Heart Failure Index, SCHFI v 6.2)
- Quality of life perception (measured using a numerical rating scale from 0 to 100) Secondary outcome measures • Number of visits to the ED (Emergency Department) and/or hospitalizations during the follow-up period after the implantation of a defibrillator (ICD).
- Mortality rate at 180 days after the implantation of the ICD due to HF-related causes.
- Infection rate in the device pocket. Data, sources and collection tools • Socio-demographic and clinical data: For all of the included patients, demographic (gender, age, educational level, marital status, country of birth (Italian citizens or foreigners), social (through a family context survey) and clinical (classification of HF using the NYHA classification, the implantation date and type of ICD, the execution of and the changes in laboratory tests and electrocardiograms results, number of perceived discharges) data will be recorded. Data on the patient's diagnosis and possible associated diseases will be obtained through the analysis of clinical documentation and will be record in accordance with the International Statistical Classification of Diseases and Related Health Problems, 9th Revision (ICD-IX).
- Economic data: For patients included in the study, the following data will be collected:
- economic activity, occupational qualifications (if employed/ex-employed);
- visits to the ED and/or hospitalizations during the follow-up period, verified through analysis of administrative documentation certifying visits and admissions (Verbal First Aid and Medical record);
- the presence of a companion for the patients during their stay in the ED or hospital as well as their economic activity and professional qualifications;
- any costs directly incurred by the patient or companion;
- time spent by the nursing figure in providing therapeutic education. From society's point of view, the benefits received in the ED and hospitalizations will be assessed according to the charge currently in force in Italy. Indirect costs, represented by the time spent by the patient, and costs related to the time spent by caregivers will be valorized using values published by official sources such as ISTAT. Costs directly charged to the patient will be valued on the basis of the stated cost. Finally, the cost of time spent in educational activities will be assessed using the hourly average cost of a nurse and/or doctor in the clinical centers that participate in this study.
- Self-Care Heart Failure Index (SCHFI) version 6.2. A tool validated in the Italian context that allows evaluation of a patient's awareness and capacity for self-care11. The obtained responses are organized on a four-level Likert scale (1 = never, 4 = every day). Specifically, this instrument is divided into three sections: Section A: (questions 1 to 10) investigates self-care skills; Section B: (questions 11 to 16) investigates an individual's symptomatology recognition skills; Section C: (questions 17 to 22) investigates the self-confidence related to self-care skills in detail. The total score is computed in the following manner: Section A: 10 is subtracted from the sum of the section results considering answers 1 to 10, and the result is multiplied by a coefficient of 3.33; Section B: 4 is subtracted from sum of the section results considering answers 11 to 16, and the result is multiplied by a coefficient of 5; Section C: 6 is subtracted from sum of the section results considering answers 17 to 22, and the result is multiplied by a coefficient of 5.56 All of the results have to be considered in terms of percentages. If the percentages for individual sections are all higher than the cut-off value (70%), then according to the literature11, the level of self-care is considered adequate. Otherwise, for lower values, the section showing an insufficient result will be strengthened.
- Numeric Rating Scale: scale from 0 to 100 used for subjective measurement of the perceived quality of life. This tool will be evaluated by a committee of experts using a pre-test, which is currently under way.
- Conditions
- Heart Failure, Arrhythmia
- Being tested
- Nursing therapeutics education
- Keywords
- Nursing, Outcome and Process Assessment, Cardiac Resynchronization Therapy Devices, Heart Failure, Education
- Medical subject headings
- Heart Failure, Arrhythmias, Cardiac
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Nursing therapeutics educationBehavioural
Educational intervention will focus on
- Appropriate lifestyles
- Early recognition of signs/prodromal symptoms of HF
- Early recognition of signs of inflammation of the ICD-pocket
- Good management of the device
- Therapy, body weight, diet, smoking, alcohol, rest, exercise, job and sex 2) Dyspnea, edema and fovea, rapid weight gain, loss of appetite, fatigue, asthenia, insomnia, mental confusion 3) Signs and symptoms of inflammation: hyperpyrexia, rubor, dolor, calor and tumor 4) Identification tag, vibration, metal detectors, air travel, use of electronic devices, diagnostic PET and MRI
| Study group | Role | What they receive |
|---|---|---|
| Nursing therapeutics education | Experimental | People who are educated by the nurse (Behavioral intervention: Nursing therapeutics education) and follow all the program (12 months) Receives: Behavioral: Nursing therapeutics education |
| Non NET | No intervention | People who receive basic information without follow the educational program but clinically controlled |
What is being measured
The primary outcome is the main question the study is designed to answer.
Self-care levels (Self-Care Heart Failure Index (SCHFI) version 6.2)
Increase of the Self Care competence, management and confidence with heart failure and the cardiac device
Measured: 12 months
Secondary outcomes (4)
Quality life perception
Increase in quality of life due to the development of management skills with heart disease
Measured: 12 months
Visits to the ED
Number of visits to the ED (Emergency Department) and/or hospitalizations during the follow-up period after the implantation of a defibrillator (ICD).
Measured: 12 months
Mortality
Mortality rate at 180 days after the implantation of the ICD due to HF-related causes
Measured: 180 days
Infection
Infection rate in the device pocket.
Measured: 10 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Apr 2015 (estimated)
- Study startApr 2015
- Primary completion29 Oct 2017
- Study completionApr 2018
Why it stopped: Feasability phase completed: Cost Evaluation
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (7)Papers the sponsor has linked to this study.
- Other trials for Heart FailureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Turin, Italy
- Sponsor type
- University, hospital or other
- Collaborators
- University of Rome Tor Vergata
- Responsible party
- Principal investigator, Prof. Maria Michela Gianino, University of Turin, Italy
- Investigators
- Maria Michela Gianino, Professor, Study director, University of Turin, ItalySebastiano Marra, MD, Study chair, University of Turin, ItalyAngela Durante, RN, Principal investigator, Catholic University of Sacred HeartRiccardo Sperlinga, MSC, Principal investigator, Catholic Universit of Sacred Heart
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02425488
- Sponsor's protocol ID
- HFICD
- Acronym
- NEHF
- Status last verified
- May 2018
- First submitted
- 20 Apr 2015
- Last updated
- 7 May 2018
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- No
Publications
Hickey A, Barker M, McGee H, O'Boyle C. Measuring health-related quality of life in older patient populations: a review of current approaches. Pharmacoeconomics. 2005;23(10):971-93. doi: 10.2165/00019053-200523100-00002.
PubMed 16235972Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002 Mar 21;346(12):877-83. doi: 10.1056/NEJMoa013474. Epub 2002 Mar 19.
PubMed 11907286Pulignano G, Del Sindaco D, Minardi G, Tarantini L, Cioffi G, Bernardi L, Di Biagio D, Leonetti S, Giovannini E. Translation and validation of the Italian version of the European Heart Failure Self-care Behaviour Scale. J Cardiovasc Med (Hagerstown). 2010 Jul;11(7):493-8. doi: 10.2459/JCM.0b013e328335fbf5.
PubMed 20407384Stromberg A. Educating nurses and patients to manage heart failure. Eur J Cardiovasc Nurs. 2002 Feb;1(1):33-40. doi: 10.1016/S1474-5151(01)00011-1.
PubMed 14622865Aspromonte N, Di Tano G, Latini R, Masson S, Valle R, Emdin M. [Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients]. G Ital Cardiol (Rome). 2010 May;11(5 Suppl 2):17S-23S. Italian.
PubMed 20873464MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJ. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000 Sep 5;102(10):1126-31. doi: 10.1161/01.cir.102.10.1126.
PubMed 10973841Cocchieri A, Riegel B, D'Agostino F, Rocco G, Fida R, Alvaro R, Vellone E. Describing self-care in Italian adults with heart failure and identifying determinants of poor self-care. Eur J Cardiovasc Nurs. 2015 Apr;14(2):126-36. doi: 10.1177/1474515113518443. Epub 2013 Dec 23.
PubMed 24366984
Study at a glance
From the registry record, last updated by the sponsor on 7 May 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Nursing Therapeutics Education and Heart Failure (HF): an Experimental Study
- ClinicalTrials.gov ID
- NCT02425488
- Acronym / sponsor ID
- NEHF / HFICD
- Conditions
- Heart Failure, Arrhythmia
- Keywords
- Nursing, Outcome and Process Assessment, Cardiac Resynchronization Therapy Devices, Heart Failure, Education
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: Feasability phase completed: Cost Evaluation
- Enrolment
- 30 participants (actual)
- Lead sponsor
- University of Turin, ItalyUniversity, hospital or other
- Collaborators
- University of Rome Tor Vergata
- Study start
- Apr 2015
- Primary completion
- 29 Oct 2017 (actual)
- Study completion
- Apr 2018 (actual)
- First posted
- 24 Apr 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Purpose: Heart Failure (HF) is a clinical multifactorial syndrome, it can cause arrhythmias for which international guidelines suggest the implantation of an implantable cardiac defibrillator (ICD). The educational nursing program would improve clinical outcomes in patients with HF and ICD like control their sickness, known and acknowledge symptoms, improve their skills to self-care.
The main aim of this study is to assess how much the nursing-therapeutics skills and an educational intervention, in patients with HF during the follow-up period after the implantation of ICD reduces clinical costs, re-hospitalizations, and mortality at 180 days.
Methods: The investigators start a multicenter randomized clinical trial. The sample is made of 128 subjects (64 patients treatment group and 64 control group). The investigators measured the self-care level administering to HF patients the "Self-Care of Heart Failure Index (SCHFI) v. 6.2", and the self-perception of own life quality using a Numeric Rating Scale from 0 to 100. Secondary outcomes recorded are i) the numbers of accesses to the ED (Emergency Department) and/or hospitalizations during the follow-up period, ii) mortality rate due to HF, and iii) infection rate of the device pocket.
Data Analysis: Categorical variables will be presented in terms of frequencies and percentages. The statistical power was fixed at the 80%. Data will be considered significant for a p-value ≤ 0.05. The Cox proportional hazards model will be used to analyze mortality in subjects involved in the educational program.
Detailed description
Aims of the study The aim of this study is to examine the effects of a nursing intervention consisting of sanitary-therapeutic education during the follow-up period after the implantation of a defibrillator (ICD) in patients with congestive heart failure.
The effectiveness of the educational intervention will be assessed on the basis of the level of "self-care" in every individual and their lifestyle as well as on mortality rates, readmission to the hospital and ICD pocket infection.
Educational intervention will focus on
- Appropriate lifestyles
- Early recognition of signs/prodromal symptoms of HF
- Early recognition of signs of inflammation of the ICD-pocket
- Good management of the device
<!-- -->
- Therapy, body weight, diet, smoking, alcohol, rest, exercise, job, and sex
- Dyspnea, edema, and fovea, rapid weight gain, loss of appetite, fatigue, asthenia, insomnia, mental confusion
- Signs and symptoms of inflammation: hyperpyrexia, rubor, dolor, calor and tumor
- Identification tag, vibration, metal detectors, air travel, use of electronic devices, diagnostic PET and MRI Materials and methods A multicenter randomized controlled study will be performed. The research project will involve two clinical centers in northern Italy: the "Città della Salute e della Scienza" University Hospital of Turin, which includes the "Molinette" Hospital (coordinator center), and the TO3 ASL, which includes the "Associated Hospitals of Rivoli". Subject recruitment and data collection will take place until data saturation is achieved, with an estimated period of approximately 12 months from the beginning of the study. Participants Inclusion criteria:
- Patients affected by heart failure following elective hospitalization during which an ICD was implanted on an arrhythmic and/or ischemic basis.
- Patients who have given written consent for the research. Exclusion criteria:
- Patients with syndromes and diseases that compromise their understanding of information, learning and all cognitive activities in general.
- Minors. Primary outcome measures • Self-care levels (measured using the Self-Care Heart Failure Index, SCHFI v 6.2)
- Quality of life perception (measured using a numerical rating scale from 0 to 100) Secondary outcome measures • Number of visits to the ED (Emergency Department) and/or hospitalizations during the follow-up period after the implantation of a defibrillator (ICD).
- Mortality rate at 180 days after the implantation of the ICD due to HF-related causes.
- Infection rate in the device pocket. Data, sources and collection tools • Socio-demographic and clinical data: For all of the included patients, demographic (gender, age, educational level, marital status, country of birth (Italian citizens or foreigners), social (through a family context survey) and clinical (classification of HF using the NYHA classification, the implantation date and type of ICD, the execution of and the changes in laboratory tests and electrocardiograms results, number of perceived discharges) data will be recorded. Data on the patient's diagnosis and possible associated diseases will be obtained through the analysis of clinical documentation and will be record in accordance with the International Statistical Classification of Diseases and Related Health Problems, 9th Revision (ICD-IX).
- Economic data: For patients included in the study, the following data will be collected:
- economic activity, occupational qualifications (if employed/ex-employed);
- visits to the ED and/or hospitalizations during the follow-up period, verified through analysis of administrative documentation certifying visits and admissions (Verbal First Aid and Medical record);
- the presence of a companion for the patients during their stay in the ED or hospital as well as their economic activity and professional qualifications;
- any costs directly incurred by the patient or companion;
- time spent by the nursing figure in providing therapeutic education. From society's point of view, the benefits received in the ED and hospitalizations will be assessed according to the charge currently in force in Italy. Indirect costs, represented by the time spent by the patient, and costs related to the time spent by caregivers will be valorized using values published by official sources such as ISTAT. Costs directly charged to the patient will be valued on the basis of the stated cost. Finally, the cost of time spent in educational activities will be assessed using the hourly average cost of a nurse and/or doctor in the clinical centers that participate in this study.
- Self-Care Heart Failure Index (SCHFI) version 6.2. A tool validated in the Italian context that allows evaluation of a patient's awareness and capacity for self-care11. The obtained responses are organized on a four-level Likert scale (1 = never, 4 = every day). Specifically, this instrument is divided into three sections: Section A: (questions 1 to 10) investigates self-care skills; Section B: (questions 11 to 16) investigates an individual's symptomatology recognition skills; Section C: (questions 17 to 22) investigates the self-confidence related to self-care skills in detail. The total score is computed in the following manner: Section A: 10 is subtracted from the sum of the section results considering answers 1 to 10, and the result is multiplied by a coefficient of 3.33; Section B: 4 is subtracted from sum of the section results considering answers 11 to 16, and the result is multiplied by a coefficient of 5; Section C: 6 is subtracted from sum of the section results considering answers 17 to 22, and the result is multiplied by a coefficient of 5.56 All of the results have to be considered in terms of percentages. If the percentages for individual sections are all higher than the cut-off value (70%), then according to the literature11, the level of self-care is considered adequate. Otherwise, for lower values, the section showing an insufficient result will be strengthened.
- Numeric Rating Scale: scale from 0 to 100 used for subjective measurement of the perceived quality of life. This tool will be evaluated by a committee of experts using a pre-test, which is currently under way.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Nursing therapeutics education | Experimental | Behavioral: Nursing therapeutics educationPeople who are educated by the nurse (Behavioral intervention: Nursing therapeutics education) and follow all the program (12 months) |
| Non NET | No intervention | –People who receive basic information without follow the educational program but clinically controlled |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Patients affected by heart failure following elective hospitalization during which an ICD was implanted on an arrhythmic and/or ischemic basis.
- Patients who have given written consent for the research.
Key exclusion criteria (2 listed)
- Patients with syndromes and diseases that compromise their understanding of information, learning and all cognitive activities in general.
- Minors.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Nursing therapeutics educationEducational intervention will focus on 1. Appropriate lifestyles 2. Early recognition of signs/prodromal symptoms of HF 3. Early recognition of signs of inflammation of the ICD-pocket 4. Good management of the device 1) Therapy, body weight, diet, smoking, alcohol, rest, exercise, job and sex 2) Dyspnea, edema and fovea, rapid weight gain, loss of appetite, fatigue, asthenia, insomnia, mental confusion 3) Signs and symptoms of inflammation: hyperpyrexia, rubor, dolor, calor and tumor 4) Identification tag, vibration, metal detectors, air travel, use of electronic devices, diagnostic PET and MRI | Behavioural | Nursing therapeutics education |
Primary outcome
Self-care levels (Self-Care Heart Failure Index (SCHFI) version 6.2)
Time frame: 12 months
Increase of the Self Care competence, management and confidence with heart failure and the cardiac device
4 secondary outcomes
Quality life perception
Time frame: 12 months
Visits to the ED
Time frame: 12 months
Mortality
Time frame: 180 days
Infection
Time frame: 10 days
Results and safety
The study was stopped early (reason given: Feasability phase completed: Cost Evaluation). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 May 2018.
- Background: PubMed 16235972Hickey A, Barker M, McGee H, O'Boyle C. Measuring health-related quality of life in older patient populations: a review of current approaches. Pharmacoeconomics. 2005;23(10):971-93. doi: 10.2165/00019053-200523100-00002.
- Background: PubMed 11907286Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002 Mar 21;346(12):877-83. doi: 10.1056/NEJMoa013474. Epub 2002 Mar 19.
- Background: PubMed 20407384Pulignano G, Del Sindaco D, Minardi G, Tarantini L, Cioffi G, Bernardi L, Di Biagio D, Leonetti S, Giovannini E. Translation and validation of the Italian version of the European Heart Failure Self-care Behaviour Scale. J Cardiovasc Med (Hagerstown). 2010 Jul;11(7):493-8. doi: 10.2459/JCM.0b013e328335fbf5.
- Background: PubMed 14622865Stromberg A. Educating nurses and patients to manage heart failure. Eur J Cardiovasc Nurs. 2002 Feb;1(1):33-40. doi: 10.1016/S1474-5151(01)00011-1.
- Background: PubMed 20873464Aspromonte N, Di Tano G, Latini R, Masson S, Valle R, Emdin M. [Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients]. G Ital Cardiol (Rome). 2010 May;11(5 Suppl 2):17S-23S. Italian.
- Results publication: PubMed 10973841MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJ. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000 Sep 5;102(10):1126-31. doi: 10.1161/01.cir.102.10.1126.
- Results publication: PubMed 24366984Cocchieri A, Riegel B, D'Agostino F, Rocco G, Fida R, Alvaro R, Vellone E. Describing self-care in Italian adults with heart failure and identifying determinants of poor self-care. Eur J Cardiovasc Nurs. 2015 Apr;14(2):126-36. doi: 10.1177/1474515113518443. Epub 2013 Dec 23.
- Italian register for dischargeLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Heart Failure
RecruitingPhase 2/3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Heart Failure, Left Ventricular Systolic Dysfunction
RecruitingPhase 1/2
HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction
Active, not recruiting
Heart Failure Patient Management and Interventions Using Continuous Patient Monitoring Outside Hospitals and Real-world Data
Chronic Heart Failure, Heart Transplant Recipient
Enrolling by invitationObservational study
Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)
Heart Failure
Not yet recruitingObservational study
Real-world Effectiveness and Safety of Savagen (Sacubitril/Valsartan) in Malaysian HFrEF Patients
Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Maria Michela Gianino, Professor study director
University of Turin, Italy
Sebastiano Marra, MD study chair
University of Turin, Italy
Angela Durante, RN principal investigator
Catholic University of Sacred Heart
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Nursing therapeutics education in people with Heart Failure and Arrhythmia, run by University of Turin, Italy at 2 sites in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 7 May 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Feasability phase completed: Cost Evaluation). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Self-care levels (Self-Care Heart Failure Index (SCHFI) version 6.2) (time frame: 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02425488, which also lists 7 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2018.